Armistice Capital, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $5.71 Billion distributed in 210 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Ptc Therapeutics, Inc. with a value of $231M, Supernus Pharmaceuticals, Inc. with a value of $152M, Immunovant, Inc. with a value of $143M, Travere Therapeutics, Inc. with a value of $131M, and Incyte Corp with a value of $91M.
Examining the 13F form we can see an decrease of $851M in the current position value, from $6.56B to 5.71B.
Armistice Capital, LLC is based out at New York, NY
Below you can find more details about Armistice Capital, LLC portfolio as well as his latest detailed transactions.
Portfolio value
$5.71 Billion
ETFs: $3.02 Billion
Healthcare: $1.87 Billion
Technology: $329 Million
Consumer Cyclical: $329 Million
Consumer Defensive: $85.6 Million
Communication Services: $38.9 Million
Basic Materials: $14.5 Million
Industrials: $11.9 Million
Other: $9.21 Million
Stock Holdings Table Market Cap. of $10 Billions to $200 Billions
